[ Price : $8.95]
Consultants Marcus Ehrhardt and Peter Behner say two drug production innovations will significantly change the currently stagnant ...[ Price : $8.95]
A ZS Associates study says point-of-care communications is growing much faster than overall direct-to-consumer communications.[ Price : $8.95]
FDA approves a Novartis NDA for Signifor (pasireotide) long-acting release for treating patients with acromegaly who have had an i...[ Price : $8.95]
Medical device lawyer Larry R. Pilot corrects a Wall Street Journal statement by former FDA commissioner David Kessler that the in...[ Price : $8.95]
In its latest batch of Warning Letters, FDA cites Repromed Fertility Center, Karl Storz GmbH, and Voss Plastics.[ Price : $8.95]
FDAs New England District Office warns Karl Storz Endovision about Quality System violations at its Charlton, MA, production facil...[ Price : $8.95]
An FDA co-designed study suggests that drug developers could conduct robust cardiac safety characterizations several years earlier...[ Price : $8.95]
FDA grants the first-ever Clinical Laboratory Improvement Amendments (CLIA) waiver for Veda Labs (Alencon, France) rapid screening...